Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAMIAN SILBERMINS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1922207117
CMS profile
268853
Location
HUNTINGTON, WV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$8,276.00

160 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $3,414.47 9
Janssen Biotech, Inc. $1,509.11 9
Exelixis Inc. $472.21 4
Novartis Pharmaceuticals Corporation $268.27 16
E.R. Squibb & Sons, L.L.C. $266.50 13
Seagen Inc. $202.50 6
Celgene Corporation $179.72 9
Genentech USA, Inc. $144.35 8
Astellas Pharma US Inc $131.18 7
PFIZER INC. $118.25 8
GENZYME CORPORATION $101.43 4
GlaxoSmithKline, LLC. $96.66 5
Merck Sharp & Dohme LLC $86.80 5
BeiGene USA, Inc. $85.55 1
TerSera Therapeutics LLC $84.46 3
Coherus Biosciences Inc. $73.66 3
Jazz Pharmaceuticals Inc. $73.20 3
Daiichi Sankyo Inc. $67.48 3
Ipsen Biopharmaceuticals, Inc $61.82 3
Incyte Corporation $59.31 3
TAIHO ONCOLOGY, INC. $55.87 2
Takeda Pharmaceuticals U.S.A., Inc. $55.35 2
Foundation Medicine, Inc. $51.80 2
Amgen Inc. $51.72 2
Pharmacyclics LLC, An AbbVie Company $49.92 3
Alnylam Pharmaceuticals Inc. $45.69 2
Karyopharm Therapeutics Inc. $40.01 2
MorphoSys, US Inc. $38.14 2
Bayer Healthcare Pharmaceuticals Inc. $35.76 2
AVEO Pharmaceuticals, Inc. $34.11 2
Rigel Pharmaceuticals, Inc. $33.18 2
EMD Serono, Inc. $32.50 1
Adaptive Biotechnologies Corporation $29.14 1
G1 Therapeutics, Inc. $22.57 1
Novocure Inc. $22.08 1
Eisai Inc. $20.00 1
Kyowa Kirin, Inc. $19.64 1
CTI BioPharma Corp. $18.21 1
Lilly USA, LLC $17.15 1
ARRAY BIOPHARMA INC $16.65 1
Puma Biotechnology, Inc. $15.58 1
AbbVie Inc. $15.33 1
Mirati Therapeutics, Inc. $14.88 1
ADC Therapeutics America, Inc. $14.79 1
Kite Pharma, Inc. $14.60 1
Gilead Sciences, Inc. $14.40 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

160 matching records · $8,276.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 160 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 160.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $17.1512/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031352909 CMS
Puma Biotechnology, Inc. $15.5812/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059049283 CMS
Coherus Biosciences Inc. $19.6112/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060243611 CMS
Ipsen Biopharmaceuticals, Inc $16.4612/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261045457853 CMS
Karyopharm Therapeutics Inc. $16.5012/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056898843 CMS
Janssen Biotech, Inc. $20.0412/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988541635 CMS
Foundation Medicine, Inc. $29.0712/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261058784963 CMS
Novartis Pharmaceuticals Corporation $24.1312/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993330037 CMS
Astellas Pharma US Inc $27.7012/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261034738759 CMS
Exelixis Inc. $33.8112/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062014271 CMS
Exelixis Inc. $379.4012/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062014299 CMS
Merck Sharp & Dohme LLC $14.7912/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048641553 CMS
Celgene Corporation $13.3512/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744263 CMS
PFIZER INC. $18.0511/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049852069 CMS
Genentech USA, Inc. $24.0011/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335237 CMS
Eisai Inc. $20.0011/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023306281 CMS
Novartis Pharmaceuticals Corporation $4.5311/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993330027 CMS
MorphoSys, US Inc. $21.8911/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060329569 CMS
Novartis Pharmaceuticals Corporation $24.7611/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993330019 CMS
Novartis Pharmaceuticals Corporation $11.5411/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993330021 CMS
AVEO Pharmaceuticals, Inc. $18.6411/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049057619 CMS
AstraZeneca Pharmaceuticals LP $1,387.5010/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261012026933 CMS
GlaxoSmithKline, LLC. $18.5210/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001610337 CMS
GENZYME CORPORATION $31.1610/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050056833 CMS
E.R. Squibb & Sons, L.L.C. $15.8910/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744223 CMS
Pharmacyclics LLC, An AbbVie Company $16.6210/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998295707 CMS
Seagen Inc. $20.4610/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995807833 CMS
Celgene Corporation $17.9110/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744233 CMS
AstraZeneca Pharmaceuticals LP $1,665.0010/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016260985 CMS
Novartis Pharmaceuticals Corporation $11.0910/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993330013 CMS
PFIZER INC. $1.1410/12/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050121783 CMS
Incyte Corporation $22.1610/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261044560575 CMS
Gilead Sciences, Inc. $14.4010/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261026012261 CMS
Jazz Pharmaceuticals Inc. $26.5810/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059098103 CMS
Genentech USA, Inc. $19.9710/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040335209 CMS
TerSera Therapeutics LLC $27.5310/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261052414989 CMS
PFIZER INC. $23.5010/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050033685 CMS
Celgene Corporation $22.6410/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744243 CMS
AstraZeneca Pharmaceuticals LP $100.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014984277 CMS
AstraZeneca Pharmaceuticals LP $100.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015861729 CMS
AstraZeneca Pharmaceuticals LP $100.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016108093 CMS
Daiichi Sankyo Inc. $20.8309/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006486423 CMS
E.R. Squibb & Sons, L.L.C. $18.6109/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744177 CMS
E.R. Squibb & Sons, L.L.C. $77.3909/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744201 CMS
EMD Serono, Inc. $32.5009/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032339673 CMS
Janssen Biotech, Inc. $27.2809/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988541611 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.6209/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261000503453 CMS
Seagen Inc. $103.1309/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995807953 CMS
E.R. Squibb & Sons, L.L.C. $14.7909/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014744187 CMS
GENZYME CORPORATION $23.8109/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050056789 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $86,908.83 236
PY2020 $20,029.23 134
PY2021 $59,378.23 173
PY2022 $6,532.96 168
PY2023 $8,276.00 160
PY2024 $34,335.87 186
PY2025 $61,435.63 184

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
DAMIAN SILBERMINS, NPI 1922207117. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1922207117.
APA 7
IndustryPayments. (2026). DAMIAN SILBERMINS, NPI 1922207117 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1922207117
Bluebook
DAMIAN SILBERMINS, NPI 1922207117, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1922207117.

Source: Centers for Medicare & Medicaid Services, Open Payments.